Prevent Cancer Foundation welcomes 2024 corporate members dedicated to cancer prevention and early detection
即时发布
凯拉·梅斯特
703-836-1746
kyra.meister@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation today announced the 13 companies who are members of their Corporate Membership Program’s 2024 cohort. Launched in 2023, the Foundation’s Corporate Membership Program was created with the goal of accelerating mutual goals and reaffirming a commitment from corporate partners to advancing cancer prevention and early detection.
Program members receive access to Foundation resources and exclusive events—including industry roundtable discussions—creating opportunities to collaborate and exchange ideas throughout the year. Membership supports the Foundation’s work in four key areas: research, education, outreach and advocacy.
“Over the last year, the Prevent Cancer Foundation has had the opportunity to see our Corporate Membership Program not only grow, but flourish.” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “Each of these companies supports our mission just as strongly as we do. By creating meaningful partnerships with experts across the industry, we are able to better guide people of screening age toward better outcomes for their health.”
The 2024 class of corporate members, as of the date of this publication, include:
金子
- 第一三共
银
- 精确科学
- Hologic
青铜
- AstraZeneca
- 百时美施贵宝
- 吉利德
- GSK
- 守护者
- 卫材
- Eli Lilly
- 默克
- Natera
- 诺华
- Sanofi
The Corporate Membership Program is open to companies who support the Foundation’s vision of a world where cancer is preventable, detectable and beatable for all. Those interested in learning more about the program or how to join this community can contact Jennifer Niyangoda, Vice President of Development and Marketing, at jennifer.niyangoda@preventcancer.org.
###
关于预防癌症基金会®
预防癌症基金会® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
基金会正奋起应对到 2035 年将癌症死亡人数减少 40% 的挑战。为实现这一目标,我们承诺投资 $2000 万美元用于创新技术,以早期发现癌症并推进多癌筛查,投资 $1000 万美元用于扩大医疗服务不足社区的癌症筛查和疫苗接种机会,并投资 $1000 万美元用于教育公众有关筛查和疫苗接种的选择。
如需了解更多信息,请访问 www.preventcancer.org.